Good MorningThe major indices held steady on Monday in what was an otherwise uneventful day of trading. The S&P 500 fell about 0.50% on an intraday basis but reclaimed about half of the loss before the close of the session. The day’s action is a sign of caution and not a little indecision. With so much riding on the economic rebound and COVID cases on the rise, a little caution is more than warranted.
This week could be a volatile one for investors. The market is waiting for the next cue and it could come from Congress at any time. Hopes for a bipartisan COVID relief bill continue to grow despite a lack of commitment from Republican leadership. If passed the bill would send another surge of stimulus through the economy but there is another risk as well. That risk is a government shut-down. A stop-gap effort to keep the government running for a week is probably not enough to get the stimulus deal done. If the aid package falls apart like it did before the market could take a dive.
Featured: Turn $1,000 into $461,800 - with "New Type of Weapon" (BehindtheMarkets) 
|
Markets | | | The S&P 500 (NYSEARCA: SPY) is grinding through all-time highs heading into year’s end as the pandemic ravages a third wave in a race for FDA COVID-19 vaccine approvals and distribution. While pundits argue the markets are disconnected with reality, this is the seasonal time of year where ... Read the Full Story |
|
|
Stocks | | | Solid-oxide fuel cell systems provider Bloom Energy (NYSE: BE) stock has seen a resurgence from the electric vehicle (EV) momentum. As momentum and money flow frantically shifts from EVs to EV fueling, power sources and materials, shares of former momentum flyers FuelCell Energy, Inc. (NASDAQ: FCEL)... Read the Full Story |
|
Politics | | | Shares were mixed in Asia on Monday following a report that the U.S. is preparing to slap sanctions on a dozen more Chinese officials, ratcheting up tensions with Beijing.
Benchmarks dropped in Tokyo, Hong Kong and Shanghai but rose in Sydney and Seoul.
China reported... Read the Full Story |
|
From Our PartnersSweeping new legalization could make investors wealthy. FREE Pot Stock Profit Calendar reveals key dates for investors. And it's yours FREE today. | | Click here to download it instantly... |
|
Politics | | | Shares fell in Europe after a mixed day of trading in Asia following a report that the U.S. is preparing to slap sanctions on a dozen more Chinese officials, ratcheting up tensions with Beijing.
That news coincided with data showing China logged a record high $75 billion trade surplu... Read the Full Story |
|
Markets | | | Chinese vaccine company Sinovac says it is planning to complete a new facility to double its annual vaccine capacity to 600 million doses by the end of the year, while also securing a $500 million investment in a boost to its COVID-19 vaccine efforts Read the Full Story |
|
From Our PartnersThere's plenty of growth in store for biotech. For one, the sector is still one of the safest, most recession-proof investments around. Two, an aging population will demand new, aggressive treatments to treat a myriad of issues. And three, with COVID-19 treatments desperately needed, biotech has taken center stage. | | Click Here to Download the FREE Report |
|
Markets | | | The chief executive of online fashion retailer Zalando is stepping down to focus on his family, saying his wife's career should “take priority” in the coming years.
Rubin Ritter, one of three co-chief executives at Zalando, has been in the job since 2010. Tasked with overseeing strate... Read the Full Story |
|
Markets | | | Industrial production in Germany, Europe's biggest economy, was up 3.2% in October compared with the previous month, according to official data released Monday. It was the second set of figures for October to beat economists' expectations.
The sixth consecutive monthly rise in product... Read the Full Story |
|
Markets | | | As if they hadn’t been performing well enough this year already, shares of mobile payment company Square (NYSE: SQ) have been on a fresh rally to all-time highs since reporting Q3 earnings a month ago Read the Full Story |
|
Markets | | | Smith & Wesson Brands (NASDAQ:SWBI) reported a fantastic fiscal 2nd quarter and it looks like these gains could stick. Based on the number of federal background checks and the number of 1st-time buyers Read the Full Story |
|
Markets | | | A Changing Landscape For Mall-Based RetailersThe mall-based brick&mortar retail industry has been on the rocks for years. The pandemic didn’t cause this problem it only accelerated a shift to digital and non-mall retailers that was already in place. What this means for many mall-based reta... Read the Full Story |
|
The Early Bird Stock Of The Day Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes brain health medicines. Its product candidates include ZULRESSO, a CIV injection for the treatment of postpartum depression (PPD) in adults; and ZURZUVAE, a neuroactive steroid, a positive allosteric modulator of GABAA receptors, targeting both synaptic and extrasynaptic GABAA receptors, for the treatment of postpartum depression. Its product pipeline also comprises SAGE-324, a compound that is in Phase II clinical trial to treat essential tremors, as well as has completed Phase I clinical trial for epilepsy and Parkinson's diseases; and SAGE-718, an oxysterol-based positive allosteric modulator of the NMDA receptor, which is in Phase II clinical trial for the treatment of depression, Huntington's disease, Parkinson's diseases, Alzheimer's disease, attention deficit hyperactivity disorder, schizophrenia, and neuropathic pain. The company has a strategic collaboration with Shionogi & Co., Ltd. for the development and commercialization of zuranolone in Japan, Taiwan, and South Korea; and a collaboration and license agreement with Biogen MA Inc. to jointly develop and commercialize SAGE-217 and SAGE-324 products. The company was formerly known as Sterogen Biopharma, Inc. and changed its name to Sage Therapeutics, Inc. in September 2011. Sage Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts. | | View Today's Stock Pick |
|
